Smoking Cessation, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology.
Abstract
Cigarette smoking has been implicated in causing many cancers and cancer deaths. There
is mounting evidence indicating that smoking negatively impacts cancer treatment efficacy
and overall survival. The NCCN Guidelines for Smoking Cessation have been created
to emphasize the importance of smoking cessation and establish an evidence-based standard
of care in all patients with cancer. These guidelines provide recommendations to address
smoking in patients and outlines behavioral and pharmacologic interventions for smoking
cessation throughout the continuum of oncology care.
Type
Journal articlePermalink
https://hdl.handle.net/10161/13073Collections
More Info
Show full item recordScholars@Duke
James Davis
Associate Professor of Medicine
Dr. James Davis is a practicing physician of Internal Medicine, and serves as the
Medical Director for Duke Center for Smoking Cessation, Director of the Duke Smoking
Cessation Program and Co-Director of the Duke-UNC Tobacco Treatment Specialist Credentialing
Program. His research focuses on development of new pharmaceutical treatments for
smoking cessation. He is principal investigator on several trials including a study
on “adaptive” smoking cessation and several trials
Articles written by Duke faculty are made available through the campus open access policy. For more information see: Duke Open Access Policy
Rights for Collection: Scholarly Articles
Works are deposited here by their authors, and represent their research and opinions, not that of Duke University. Some materials and descriptions may include offensive content. More info